Figure 2. Development and evaluation of nomogram. (A, B) Univariate and multivariate analyses of ARG_score and clinical traits in TCGA cohort. (C–H) Subgroup survival analysis based on age ≤ 65, age > 65 years, female, male, stage I-II, and stage III-IV. (I) The relationship of risk score and TNM stage. (J) Nomogram of angiogenesis-related risk score and clinical characteristics. (K) ROC curve analysis for risk score. (L) Calibration plot for evaluating the predictive ability of the nomogram at 1-, 3-, and 5-years.